{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:03:53Z","timestamp":1791288233774,"version":"4.3.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12640-013-9401-8","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T15:45:17Z","timestamp":1369064717000},"page":"24-32","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Fabrine S. M.","family":"Trist\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Latrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Del-Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Raisman-Vozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"9401_CR1","doi-asserted-by":"crossref","unstructured":"Aguiar AS Jr., Tristao FSM, Amar M, Chevarin C, Lanfumey L, Mongeau R, Corti O, Prediger RD, Raisman-Vozari R (2013) Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurotox Res. doi: 10.1007\/s12640-013-9389-0","DOI":"10.1007\/s12640-013-9389-0"},{"key":"9401_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2012.05.039","volume":"218","author":"A Anandhan","year":"2012","unstructured":"Anandhan A, Janakiraman U, Manivasagam T (2012) Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson\u2019s disease. Neuroscience 218:257\u2013267","journal-title":"Neuroscience"},{"key":"9401_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2008.10.004","volume":"86","author":"E Aoki","year":"2009","unstructured":"Aoki E, Yano R, Yokoyama H, Kato H, Araki T (2009) Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Exp Mol Pathol 86:57\u201364","journal-title":"Exp Mol Pathol"},{"key":"9401_CR4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","volume":"71","author":"N Aubin","year":"1998","unstructured":"Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71:1635\u20131642","journal-title":"J Neurochem"},{"key":"9401_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"PA Ballard","year":"1985","unstructured":"Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949\u2013956","journal-title":"Neurology"},{"key":"9401_CR6","doi-asserted-by":"crossref","unstructured":"Bezard E, Yue Z, Kirik D, Spillantini MG (2012) Animal models of Parkinson\u2019s disease: limits and relevance to neuroprotection studies. Mov Disord. doi: 10.1002\/mds.25108","DOI":"10.1002\/mds.25108"},{"key":"9401_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77\u201398","journal-title":"Prog Neurobiol"},{"key":"9401_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","volume":"211","author":"J Bove","year":"2012","unstructured":"Bove J, Perier C (2012) Neurotoxin-based models of Parkinson\u2019s disease. Neuroscience 211:51\u201376","journal-title":"Neuroscience"},{"key":"9401_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bove","year":"2005","unstructured":"Bove J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson\u2019s disease. NeuroRx 2:484\u2013494","journal-title":"NeuroRx"},{"key":"9401_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","volume":"229","author":"AA Castro","year":"2012","unstructured":"Castro AA, Ghisoni K, Latini A, Quevedo J, Tasca CI, Prediger RD (2012) Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson\u2019s disease. Behav Brain Res 229:208\u2013215","journal-title":"Behav Brain Res"},{"key":"9401_CR11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(25)22211-X","volume":"246","author":"K Chiba","year":"1988","unstructured":"Chiba K, Kubota E, Miyakawa T, Kato Y, Ishizaki T (1988) Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Pharmacol Exp Ther 246:1108\u20131115","journal-title":"J Pharmacol Exp Ther"},{"key":"9401_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","volume":"100","author":"CC Chiueh","year":"1984","unstructured":"Chiueh CC, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ (1984) Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol 100:189\u2013194","journal-title":"Eur J Pharmacol"},{"key":"9401_CR13","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","volume":"25","author":"DK Choi","year":"2005","unstructured":"Choi DK, Pennathur S, Perier C, Tieu K, Teismann P, Wu DC, Jackson-Lewis V, Vila M, Vonsattel JP, Heinecke JW, Przedborski S (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice. J Neurosci 25:6594\u20136600","journal-title":"J Neurosci"},{"key":"9401_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","volume":"43","author":"YC Chung","year":"2010","unstructured":"Chung YC, Ko HW, Bok E, Park ES, Huh SH, Nam JH, Jin BK (2010) The role of neuroinflammation on the pathogenesis of Parkinson\u2019s disease. BMB Rep 43:225\u2013232","journal-title":"BMB Rep"},{"key":"9401_CR15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00011-009-0026-6","volume":"58","author":"A Ciesielska","year":"2009","unstructured":"Ciesielska A, Joniec I, Kurkowska-Jastrzebska I, Cudna A, Przybylkowski A, Czlonkowska A, Czlonkowski A (2009) The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson\u2019s disease. Inflamm Res 58:747\u2013753","journal-title":"Inflamm Res"},{"key":"9401_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"key":"9401_CR17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"9401_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(96)00934-1","volume":"741","author":"DE Dluzen","year":"1996","unstructured":"Dluzen DE, Kefalas G (1996) The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Brain Res 741:215\u2013219","journal-title":"Brain Res"},{"key":"9401_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.21327","volume":"63","author":"RL Doty","year":"2008","unstructured":"Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol 63:7\u201315","journal-title":"Ann Neurol"},{"key":"9401_CR20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3171\/2009.2.JNS081199","volume":"111","author":"L Fletcher","year":"2009","unstructured":"Fletcher L, Kohli S, Sprague SM, Scranton RA, Lipton SA, Parra A, Jimenez DF, Digicaylioglu M (2009) Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke: laboratory investigation. J Neurosurg 111:164\u2013170","journal-title":"J Neurosurg"},{"key":"9401_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"9401_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-4274(90)90192-O","volume":"54","author":"RW Fuller","year":"1990","unstructured":"Fuller RW, Hemrick-Luecke SK (1990) Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice. Toxicol Lett 54:253\u2013262","journal-title":"Toxicol Lett"},{"key":"9401_CR23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2009.06072.x","volume":"109","author":"C Gibrat","year":"2009","unstructured":"Gibrat C, Saint-Pierre M, Bousquet M, Levesque D, Rouillard C, Cicchetti F (2009) Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J Neurochem 109:1469\u20131482","journal-title":"J Neurochem"},{"key":"9401_CR24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature07525","volume":"456","author":"GR Gordon","year":"2008","unstructured":"Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA (2008) Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456:745\u2013749","journal-title":"Nature"},{"key":"9401_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"9401_CR26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334:345\u2013348","journal-title":"Nature"},{"key":"9401_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257\u2013269","journal-title":"Neurodegeneration"},{"key":"9401_CR28","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","volume":"84","author":"RN Kalaria","year":"1987","unstructured":"Kalaria RN, Mitchell MJ, Harik SI (1987) Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Proc Natl Acad Sci USA 84:3521\u20133525","journal-title":"Proc Natl Acad Sci USA"},{"key":"9401_CR29","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102:5215\u20135220","journal-title":"Proc Natl Acad Sci USA"},{"key":"9401_CR60","first-page":"1403","volume":"5","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M, Vozari RR, St\u00fchmer W, Bel ED (2013) Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia. doi: 10.1002\/glia.22496","journal-title":"Nat Med"},{"key":"9401_CR30","first-page":"920","volume-title":"Pathologische Anatomie. Handbuch der Neurologie","author":"FH Lewy","year":"1912","unstructured":"Lewy FH (1912) Paralysis agitans. In: Lewandowsky M (ed) Pathologische Anatomie. Handbuch der Neurologie. Springer-Verlag, Berlin, pp 920\u2013933"},{"key":"9401_CR31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403\u20131409","journal-title":"Nat Med"},{"key":"9401_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","volume":"26","author":"R Mayeux","year":"2003","unstructured":"Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81\u2013104","journal-title":"Annu Rev Neurosci"},{"key":"9401_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in Parkinsonism indicates active neuropathological process. Ann Neurol 24:574\u2013576","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"9401_CR34","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","volume":"14","author":"GE Meredith","year":"2008","unstructured":"Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14(Suppl 2):S112\u2013S115","journal-title":"Parkinsonism Relat Disord"},{"key":"9401_CR35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165:208\u2013210","journal-title":"Neurosci Lett"},{"key":"9401_CR36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","volume":"117","author":"EL Moreira","year":"2010","unstructured":"Moreira EL, Rial D, Aguiar AS Jr, Figueiredo CP, Siqueira JM, DalBo S, Horst H, de Oliveira J, Mancini G, dos Santos TS, Villarinho JG, Pinheiro FV, Marino-Neto J, Ferreira J, De Bem AF, Latini A, Pizzolatti MG, Ribeiro-do-Valle RM, Prediger RD (2010) Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson\u2019s disease. J Neural Transm 117:1337\u20131351","journal-title":"J Neural Transm"},{"key":"9401_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature02827","volume":"431","author":"SJ Mulligan","year":"2004","unstructured":"Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431:195\u2013199","journal-title":"Nature"},{"key":"9401_CR38","first-page":"277","volume":"60","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson\u2019s disease. J Neural Transm 60:277\u2013290","journal-title":"J Neural Transm"},{"key":"9401_CR39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","volume":"106","author":"E Petroske","year":"2001","unstructured":"Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment. Neuroscience 106:589\u2013601","journal-title":"Neuroscience"},{"key":"9401_CR40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","volume":"202","author":"RD Prediger","year":"2006","unstructured":"Prediger RD, Batista LC, Medeiros R, Pandolfo P, Florio JC, Takahashi RN (2006) The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson\u2019s disease. Exp Neurol 202:391\u2013403","journal-title":"Exp Neurol"},{"key":"9401_CR41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"RD Prediger","year":"2010","unstructured":"Prediger RD, Aguiar AS Jr, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease. Neurotox Res 17:114\u2013129","journal-title":"Neurotox Res"},{"key":"9401_CR42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00702-010-0568-3","volume":"118","author":"RD Prediger","year":"2011","unstructured":"Prediger RD, Rojas-Mayorquin AE, Aguiar AS Jr, Chevarin C, Mongeau R, Hamon M, Lanfumey L, Del Bel E, Muramatsu H, Courty J, Raisman-Vozari R (2011) Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson\u2019s disease. J Neural Transm 118:1215\u20131225","journal-title":"J Neural Transm"},{"key":"9401_CR43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12640-011-9281-8","volume":"21","author":"RD Prediger","year":"2012","unstructured":"Prediger RD, Aguiar AS Jr, Matheus FC, Walz R, Antoury L, Raisman-Vozari R, Doty RL (2012) Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson\u2019s disease. Neurotox Res 21:90\u2013116","journal-title":"Neurotox Res"},{"key":"9401_CR44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","volume":"991","author":"S Przedborski","year":"2003","unstructured":"Przedborski S, Vila M (2003) The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson\u2019s disease. Ann N Y Acad Sci 991:189\u2013198","journal-title":"Ann N Y Acad Sci"},{"key":"9401_CR45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265\u20131274","journal-title":"J Neurochem"},{"key":"9401_CR46","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1460-9568.2006.05060.x","volume":"24","author":"AI Rojo","year":"2006","unstructured":"Rojo AI, Montero C, Salazar M, Close RM, Fernandez-Ruiz J, Sanchez-Gonzalez MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A (2006) Persistent penetration of MPTP through the nasal route induces Parkinson\u2019s disease in mice. Eur J Neurosci 24:1874\u20131884","journal-title":"Eur J Neurosci"},{"key":"9401_CR47","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744\u20131754","journal-title":"J Clin Invest"},{"key":"9401_CR48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","volume":"30","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30:171\u2013182","journal-title":"Behav Genet"},{"key":"9401_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson\u2019s disease. Brain Res Mol Brain Res 134:57\u201366","journal-title":"Brain Res Mol Brain Res"},{"key":"9401_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208","journal-title":"Neurosci Lett"},{"key":"9401_CR51","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","volume":"16","author":"K Sriram","year":"2002","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O\u2019Callaghan JP (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease. FASEB J 16:1474\u20131476","journal-title":"FASEB J"},{"key":"9401_CR52","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","volume":"94","author":"N Takahashi","year":"1997","unstructured":"Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938\u20139943","journal-title":"Proc Natl Acad Sci USA"},{"key":"9401_CR53","first-page":"140","volume":"36","author":"S Talegaonkar","year":"2004","unstructured":"Talegaonkar S, Mishra PR (2004) Intranasal delivery: an approach to bypass the blood brain barrier. Indian J Pharmacol 36:140\u2013147","journal-title":"Indian J Pharmacol"},{"key":"9401_CR54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510\u2013518","journal-title":"Neurobiol Dis"},{"key":"9401_CR55","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","volume":"77","author":"NA Tatton","year":"1997","unstructured":"Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77:1037\u20131048","journal-title":"Neuroscience"},{"key":"9401_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1471-4159.1973.tb12126.x","volume":"20","author":"DB Tower","year":"1973","unstructured":"Tower DB, Young OM (1973) The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 20:269\u2013278","journal-title":"J Neurochem"},{"key":"9401_CR57","first-page":"108","volume":"66","author":"MC Vanzani","year":"2006","unstructured":"Vanzani MC, Iacono RF, Caccuri RL, Troncoso AR, Berria MI (2006) Regional differences in astrocyte activation in HIV-associated dementia. Medicina (B Aires) 66:108\u2013112","journal-title":"Medicina (B Aires)"},{"key":"9401_CR58","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1037\/a0017401","volume":"123","author":"WF Wang","year":"2009","unstructured":"Wang WF, Wu SL, Liou YM, Wang AL, Pawlak CR, Ho YJ (2009) MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats. Behav Neurosci 123:1261\u20131270","journal-title":"Behav Neurosci"},{"key":"9401_CR59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.11.006","volume":"208","author":"AL Wang","year":"2010","unstructured":"Wang AL, Liou YM, Pawlak CR, Ho YJ (2010) Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats. Behav Brain Res 208:38\u201346","journal-title":"Behav Brain Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-013-9401-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-013-9401-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:40:13Z","timestamp":1746009613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-013-9401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1007\/s12640-013-9401-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}